FDA Approves First Respiratory Syncytial Virus (RSV) Vaccine | FDA

Today, the U.S. Food and Drug Administration approved Arexvy, the first respiratory syncytial virus (RSV) vaccine approved for use in the United States. Arexvy is approved for the prevention of lower respiratory tract disease caused by RSV in individuals 60 years of age and older.“Older adults, in particular those with underlying health conditions, such as heart or lung disease or weakened immune systems, are at high risk for severe disease caused by RSV,” said PeterContinue…

Click here to continue!

Matthew Cortland Hosts Twitter Space: Is it safe to ____?

Disability activist and inspiration for this site and the term adaptive PPE, Matthew Cortland is hosting a Twitter space to help people learn how to manage air quality in indoor spaces and generally protect themselves as the pandemic continues.

Join the conversation!

Vaping Does Not Increase Covid-19 Risk or Severity

A Mayo Clinic study has concluded that vaping (use of electronic cigarettes) does not increase a person’s risk of contracting Covid-19 or the severity of symptoms if contracted. This is not to say that a person should continue vaping during the weeks after diagnosis or while symptomatic. It just means that vaping won’t make you more likely to catch “the Rona”, and having vaped doesn’t mean your symptoms will be worse. As many doctors andContinue…

Click here to continue!

Expect Delays in Medicines and Supplies as USPS Hounded and Said to be Compromised By Trump Administration

Is the U.S. Postal Service compromised? Is the Trump administration purposefully sabotaging the mail to add weight to claims of voter fraud risk? The people and the unions want to know.

Click here to continue!